The FDA issued a GranuFlo recall and NaturaLyte recall in March 2012 after Fresenius Medical Care (FMC) sent an internal memo to its own dialysis centers highlighting the increased risk of cardiopulmonary arrest, stroke and heart attack caused by GranuFlo and NaturaLyte products. Unfortunately, the manufacturer did not offer the same warning to thousands of other physicians and clinics not owned by FMC.
The federal court litigation is consolidated in Boston and the Court held its first hearing September 27. More than 100 cases are filed in the Multidistrict Litigation (MDL) and more than 200 cases are pending in state courts in Boston. Lawyers for Plaintiffs are concentrating their efforts in that location since the manufacturer is located in Boston. The lawsuits uniformly allege that dialysis patients suffered sudden cardiac death after their treatments as a result of effects from GranuFlo used in their treatment.
Frank Woodson, a lawyer in our firm’s Mass Torts Section, was appointed to the Plaintiffs Steering Committee by U.S. District Judge Douglas P. Woodlock. If you have any questions about this litigation or believe you have a potential claim, Frank can be reached at 800-898-2034 or by email at Frank.Woodson@beasleyallen.com.
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.